StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note issued to investors on Saturday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
View Our Latest Stock Analysis on SNES
SenesTech Trading Up 0.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- What is the MACD Indicator and How to Use it in Your Trading
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- The How And Why of Investing in Oil Stocks
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How Technical Indicators Can Help You Find Oversold Stocks
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
